{"retracted":false,"update":{"timestamp":1490054400000,"doi":"10.1161/cir.0000000000000495","type":"correction"},"doi":"10.1161/circulationaha.116.025783","journal":"Circulation","publisher":"Ovid Technologies (Wolters Kluwer Health)","title":"Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy"}
